SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001628279-22-000521
Filing Date
2022-12-29
Accepted
2022-12-29 12:34:05
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2119142
2 backcoverlogoa.jpg GRAPHIC 21702
3 business11e.jpg GRAPHIC 1640834
4 business12b.jpg GRAPHIC 270397
5 business13c.jpg GRAPHIC 460357
6 business1c.jpg GRAPHIC 365689
7 business2ea.jpg GRAPHIC 1324773
8 business3ba.jpg GRAPHIC 671014
9 business4ba.jpg GRAPHIC 386220
10 business5d.jpg GRAPHIC 2116414
11 business6ba.jpg GRAPHIC 148220
12 business7e.jpg GRAPHIC 1449669
13 business8d.jpg GRAPHIC 393695
14 business9c.jpg GRAPHIC 631115
15 busniess10d.jpg GRAPHIC 616213
16 mineralyslogob.jpg GRAPHIC 30240
17 mineralyslogoc.jpg GRAPHIC 34244
  Complete submission text file 0001628279-22-000521.txt   16167340
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-06446 | Film No.: 221497784
SIC: 2834 Pharmaceutical Preparations